(2E)-1-(2,5-dichlorophenyl)-3-phenylprop-2-en-1-one, 95.0%, 10g

(1R,3s,5S)-Methyl 6-oxabicyclo[3.1.0]hexane-3-carboxylate, 95.0%, 1g

N-Benzylpiperidin-3-amine, 98%, 500mg

1-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-histidine, 98%, 1g

2,5-Dioxopyrrolidin-1-yl 2,2,2-trifluoroacetate, 97%, 5g

Bismuth(III) oxide, min. 99.5%, pa, 500 g, plastic packaging.

2-(Benzyloxy)pyridin-3-amine, 95+%, 100mg

1-Chloro-4-(difluoromethyl)benzene, 98.0%, 5g

Diethyl 3-(benzyloxy)cyclobutane-1,1-dicarboxylate, 95.0%, 100mg

1,1-DIFLUOROSPIRO[2.5]OCTANE-6-CARBOXYLIC ACID, 95.0%, 100mg

Ethyl 2-amino-5-chloropyrazolo[1,5-a]pyrimidine-3-carboxylate, 97%, 1g

2-Methyloxazole-5-carbonitrile, 98+%, 250mg

(6-(Trifluoromethoxy)pyridin-3-yl)boronic acid, 95.0%, 5g